Enrofloxacin 50 mg/ml Solution for Injection
Nchi: Ugiriki
Lugha: Kiingereza
Chanzo: HMA (Heads of Medicines Agencies)
Tabia za bidhaa
(SPC)
21-08-2013
Hati zingine za bidhaa hii hazipatikani kwa sasa, unaweza kutuma ombi kwa huduma ya wateja wetu na tutakuarifu mara tu tutakapopata.
Tuma ombi.
Tuma ombi.
Viambatanisho vya kazi:
enrofloxacin 50 mg/ml
Inapatikana kutoka:
Pfizer Limited
ATC kanuni:
QM01AC06
Dawa fomu:
Solution for injection
Kundi la matibabu:
meloxicam
Eneo la matibabu:
Cats, Cattle, Dogs, Pigs
Idhini ya tarehe:
2011-12-21
Tabia za bidhaa
Issued: February 2012
AN: 01748/2010
Page 1 of 8
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Reneval 50 mg/ml Solution for Injection for cattle, pigs, dogs and cats.
Reneval (DK)
Reneval vet. 50 mg/ml Solution for Injection for cattle, pigs, dogs and cats. (FI,
SE)
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each 1 ml of solution contains:
Active substance
Enrofloxacin
50.0 mg
Excipients
n-Butanol
30.0 mg
For full list of excipients, see section 6.1
3.
PHARMACEUTICAL FORM
Solution for injection.
Clear light yellow solution free from particulate matter.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Cattle, Pigs, Dogs and Cats.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Cattle:
Diseases of the respiratory and alimentary tract of bacterial or mycoplasmal
origin (e.g. _pasteurellosis, mycoplasmosis, coli-bacillosis, coli-septicaemia and _
salmonellosis) and secondary bacterial infections subsequent to viral
conditions (e.g. viral pneumonia), where clinical experience, supported where
possible by sensitivity testing of the causal organism, indicates enrofloxacin as
the drug of choice.
Issued: February 2012
AN: 01748/2010
Page 2 of 8
Pigs:
Diseases of the respiratory and alimentary tract of bacterial or mycoplasmal
origin (e.g. _pasteurellosis, actinobacillosis, mycoplasmosis, coli-bacillosis, coli-_
_septicaemia and _salmonellosis) and multifactorial diseases such as atrophic
rhinitis and enzootic pneumonia, where clinical experience, supported where
possible by sensitivity testing of the causal orga
Soma hati kamili
